Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02677532Phase 4Completed
Phase 4, randomised, open-label trial of levobupivacaine in postoperative pain (2 arms), sponsored by University of Genoa. Primary endpoint: Average postoperative pain assessed with numeric rating scale (NRS) at 48 hours. Started Dec 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02677532.